Access the full text.
Sign up today, get DeepDyve free for 14 days.
Katie Herbst-Robinson, Li Liu, Michael James, Yuemang Yao, S. Xie, K. Brunden (2015)
Inflammatory Eicosanoids Increase Amyloid Precursor Protein Expression via Activation of Multiple Neuronal ReceptorsScientific Reports, 5
G. Riccioni, C. Ilio, P. Conti, T. Theoharides, N. D’Orazio (2004)
Advances in therapy with antileukotriene drugs.Annals of clinical and laboratory science, 34 4
R. Spiller, R. Spiller, Qasim Aziz, F. Creed, A. Emmanuel, L. Houghton, P. Hungin, Roger Jones, D. Kumar, G. Rubin, N. Trudgill, P. Whorwell (2007)
Guidelines on the irritable bowel syndrome: mechanisms and practical managementGut, 56
N. Manabe, Toshiaki Tanaka, J. Hata, H. Kusunoki, K. Haruma (2009)
Pathophysiology underlying irritable bowel syndrome--from the viewpoint of dysfunction of autonomic nervous system activity.Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 45 1
Guo-liang Yu, E. Wei, Meng-ling Wang, Wei-Ping Zhang, Shihong Zhang, Jie-Qun Weng, L. Chu, S. Fang, Yu Zhou, Zhong Chen, Qi Zhang, Li-hui Zhang (2005)
Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in miceBrain Research, 1053
I. İnce, O. Yoruk, A. Ahıskalıoğlu, M. Aksoy, A. Dostbil, M. Çelik (2015)
Does Montelukast Have an Effect on Post-tonsillectomy Pain Control in Children? A Randomized Trial StudyOtolaryngology–Head and Neck Surgery, 153
Yan-jun Zhang, Lei Zhang, Shao-bin Wang, Hua-Hao Shen, E. Wei (2004)
Montelukast modulates lung CysLT(1) receptor expression and eosinophilic inflammation in asthmatic mice.Acta pharmacologica Sinica, 25 10
R. Holma, P. Salmenperä, A. Riutta, I. Virtanen, R. Korpela, H. Vapaatalo (2001)
Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats.European journal of pharmacology, 429 1-3
Pariya Khodabakhsh, Maryam Bazrgar, L. Dargahi, F. Mohagheghi, A. Taei, S. Parvardeh, A. Ahmadiani (2021)
Does Alzheimer's disease stem in the gastrointestinal system?Life sciences
Xing He, Lihong Cui, Xiao-hui Wang, Zhi-hui Yan, Chao Li, San-Dong Gong, Yan Zheng, Zhe Luo, Ying Wang (2017)
Modulation of inflammation by toll-like receptor 4/nuclear factor-kappa B in diarrhea-predominant irritable bowel syndromeOncotarget, 8
W. Fee (2002)
Irritable bowel syndrome helped by montelukast.Chest, 122 4
R. Porsolt, A. Bertin, M. Jalfre (1977)
Behavioral despair in mice: a primary screening test for antidepressants.Archives internationales de pharmacodynamie et de therapie, 229 2
Saereh Hosseindoost, S. Hashemizadeh, Zeinab Gharaylou, A. Dehpour, S. Javadi, B. Arjmand, M. Hadjighassem (2020)
β2-Adrenergic Receptor Stimulation Upregulates Cx43 Expression on Glioblastoma Multiforme and Olfactory Ensheathing CellsJournal of Molecular Neuroscience, 70
H. Qin, Hai-tao Xiao, Justin Wu, B. Berman, J. Sung, Z. Bian (2012)
Key factors in developing the trinitrobenzene sulfonic acid-induced post-inflammatory irritable bowel syndrome model in rats.World journal of gastroenterology, 18 20
A. Mahgoub, A. El-Medany, Hanan Hager, A. Mustafa, Doryia El-Sabah (2003)
Evaluating the prophylactic potential of zafirlukast against the toxic effects of acetic acid on the rat colon.Toxicology letters, 145 1
Afsaneh Taei, S. Nasoohi, G. Hassanzadeh, M. Kadivar, L. Dargahi, Maryam Farahmandfar (2021)
Enhancement of angiogenesis and neurogenesis by intracerebroventricular injection of secretome from human embryonic stem cell-derived mesenchymal stem cells in ischemic stroke model.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 140
J. La, Taewan Kim, T. Sung, J. Kang, Hyun-Ju Kim, I. Yang (2003)
Visceral hypersensitivity and altered colonic motility after subsidence of inflammation in a rat model of colitis.World journal of gastroenterology, 9 12
Hosein Shamshiri, P. Paragomi, M. Paydar, L. Moezi, M. Bahadori, Behnaz Behfar, F. Ardalan, A. Dehpour (2009)
Antinociceptive effect of chronic lithium on visceral hypersensitivity in a rat model of diarrhea‐predominant irritable bowel syndrome: The role of nitric oxide pathwayJournal of Gastroenterology and Hepatology, 24
E. Al‐Chaer, M. Kawasaki, P. Pasricha (2000)
A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development.Gastroenterology, 119 5
R Abdullayev (2021)
2993Ann Rom Soc Cell Biol, 25
Hao Wang, Qiaojuan Shi, Wen‐Zhen Shi, Xia-yan Zhang, Xiao-rong Wang, Li-hui Zhang, S. Fang, Yunbi Lu, Wei-Ping Zhang, Erqing Wei (2013)
[Expression and distribution of cysteinyl leukotriene receptors CysLT1R and CysLT2R, and GPR17 in brain of Parkinson disease model mice].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 42 1
Shinji Maeba, T. Ichiyama, Y. Ueno, H. Makata, T. Matsubara, S. Furukawa (2005)
Effect of montelukast on nuclear factor kappaB activation and proinflammatory molecules.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 94 6
K. Metters (1995)
Leukotriene receptors.Journal of lipid mediators and cell signalling, 12 2-3
R Abdullayev, L Makhmudova (2021)
Features of chemical elements in various forms of irritable bowel syndromeAnn Rom Soc Cell Biol, 25
Liefeng Wang, Changsheng Du, Jie Lv, Wei Wei, Ye Cui, Xin Xie (2011)
Autoimmune EncephalomyelitisExperimental Infiltration and Pathogenesis of Nervous System Inflammatory Cell Leukotriene Receptor 1 Alleviate Central Antiasthmatic Drugs Targeting the Cysteinyl
S. Pournajaf, Neda Valian, Leila Shalmani, Pariya Khodabakhsh, M. Jorjani, L. Dargahi (2020)
Fingolimod increases oligodendrocytes markers expression in epidermal neural crest stem cells.European journal of pharmacology
T. Liebregts, B. Adam, Christoph Bredack, A. Röth, S. Heinzel, S. Lester, S. Downie-Doyle, Eric Smith, P. Drew, N. Talley, G. Holtmann (2007)
Immune activation in patients with irritable bowel syndrome.Gastroenterology, 132 3
DF Schoors, M. Smet, T. Reiss, D. Margolskee, H. Cheng, P. Larson, R. Amin, G. Somers (1995)
Single dose pharmacokinetics, safety and tolerability of MK-0476, a new leukotriene D4-receptor antagonist, in healthy volunteers.British journal of clinical pharmacology, 40 3
K. Livak, Thomas Schmittgen (2001)
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.Methods, 25 4
Yuanjun Dong, D. Baumeister, S. Berens, W. Eich, J. Tesarz (2019)
High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary CareFrontiers in Psychiatry, 10
R. Holma, P. Salmenperä, I. Virtanen, H. Vapaatalo, R. Korpela (2007)
Prophylactic potential of montelukast against mild colitis induced by dextran sulphate sodium in rats.Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 58 3
H. Al-kuraishy, Ali Al-Gareeb, Y. Almulaiky, N. Cruz-Martins, G. Batiha (2021)
Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entityEuropean Journal of Pharmacology, 904
B. Tel, Gokçen Telli, S. Onder, E. Nemutlu, T. Bozkurt (2020)
Investigation of the relationship between chronic montelukast treatment, asthma and depression-like behavior in miceExperimental and Therapeutic Medicine, 21
Xu Yu, R. Dong, Hui Wang, Jing-ran Lin, Yun-Qi An, Yong Du, Susu Tang, Mei Hu, Yan Long, Hong Sun, L. Kong, H. Hong (2016)
Knockdown of hippocampal cysteinyl leukotriene receptor 1 prevents depressive behavior and neuroinflammation induced by chronic mild stress in micePsychopharmacology, 233
V. Capra, M. Bäck, S. Barbieri, M. Camera, E. Tremoli, G. Rovati (2013)
Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and StrokeMedicinal Research Reviews, 33
Nitesh Sanghai, G. Tranmer (2020)
Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptomsDrug Discovery Today, 25
M. Bäck, W. Powell, S. Dahlén, J. Drazen, Jilly Evans, C. Serhan, Takao Shimizu, T. Yokomizo, G. Rovati (2014)
Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7British Journal of Pharmacology, 171
P. Paragomi, R. Rahimian, M. Kazemi, M. Gharedaghi, Amin Khalifeh-Soltani, S. Azary, A. Javidan, Kamran Moradi, Stephen Sakuma, A. Dehpour (2014)
Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea‐predominant irritable bowel syndrome: Role of nitric oxideClinical and Experimental Pharmacology and Physiology, 41
A. Mohamadin, A. Elberry, Mohamed Elkablawy, H. Gawad, F. Al-Abbasi (2011)
Montelukast, a leukotriene receptor antagonist abrogates lipopolysaccharide-induced toxicity and oxidative stress in rat liver.Pathophysiology : the official journal of the International Society for Pathophysiology, 18 3
E. Colomier, J. Algera, C. Melchior (2021)
Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With DiarrheaFrontiers in Pharmacology, 11
Z. Kassam, S. Collins, P. Moayyedi (2013)
Peripheral mechanisms in irritable bowel syndrome.The New England journal of medicine, 368 6
L Wang, C Du, J Lv, W Wei, Y Cui, X Xie (2011)
Antiasthmatic drugs targeting the cysteinyl leukotriene receptor 1 alleviate central nervous system inflammatory cell infiltration and pathogenesis of experimental autoimmune encephalomyelitisJ Immunol, 187
D. Cangemi, B. Lacy (2019)
Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventionsTherapeutic Advances in Gastroenterology, 12
T. Sung, J. La, T. Kang, Tae Kim, I. Yang (2015)
Visceral Hypersensitivity and Altered Colonic Motility in Type 2 Diabetic RatJournal of Neurogastroenterology and Motility, 21
Behnam Ghorbanzadeh, M. Mansouri, H. Sahraei, Soheila Alboghobeish (2016)
Involvement of opioid receptors in the systemic and peripheral antinociceptive actions of montelukast in the animal models of pain.European journal of pharmacology, 779
Xue-qin Huang, Xia-yan Zhang, Xiao-rong Wang, Shu-ying Yu, S. Fang, Yun‐Bi Lu, Wei-Ping Zhang, E. Wei (2012)
Transforming growth factor β1-induced astrocyte migration is mediated in part by activating 5-lipoxygenase and cysteinyl leukotriene receptor 1Journal of Neuroinflammation, 9
A. Nayak, R. Langdon (2012)
Montelukast in the Treatment of Allergic RhinitisDrugs, 67
Cecilia Magnusson, M. Mezhybovska, E. Lörinc, E. Fernebro, M. Nilbert, A. Sjölander (2010)
Low expression of CysLT1R and high expression of CysLT2R mediate good prognosis in colorectal cancer.European journal of cancer, 46 4
L. Kabasakal, G. Şener, Ş. Çetinel, G. Contuk, N. Gedik, B. Yeğen (2005)
Burn-induced oxidative injury of the gut is ameliorated by the leukotriene receptor blocker montelukast.Prostaglandins, leukotrienes, and essential fatty acids, 72 6
M Camilleri (2012)
Peripheral mechanisms in irritable bowel syndromeN Engl J Med, 367
Chenghua Zhou, Xiaotian Shi, He Huang, Yang-zi Zhu, Yuqing Wu (2014)
Montelukast Attenuates Neuropathic Pain Through Inhibiting p38 Mitogen-Activated Protein Kinase and Nuclear Factor-Kappa B in a Rat Model of Chronic Constriction InjuryAnesthesia & Analgesia, 118
Shu-ying Yu, Xia-yan Zhang, Xiao-rong Wang, Dong-min Xu, Lu Chen, Li-hui Zhang, S. Fang, Yun‐Bi Lu, Wei-Ping Zhang, E. Wei (2013)
Cysteinyl leukotriene receptor 1 mediates LTD4-induced activation of mouse microglial cells in vitro, 35
H Wang, Q Shi, W Shi, X Zhang, X Wang, L Zhang, S Fang, Y Lu, W Zhang, E Wei (2013)
Expression and distribution of cysteinyl leukotriene receptors cyslt1r and cyslt2r, and gpr17 in brain of parkinson disease model mice. Zhejiang da xue xue bao. Yi xue ban= journal of zhejiang universityMed Sci, 42
L. Pons, M. Droy-lefaix, L. Buéno (1992)
Leukotriene D4 participates in colonic transit disturbances induced by intracolonic administration of trinitrobenzene sulfonic acid in rats.Gastroenterology, 102 1
Guo-liang Yu, E. Wei, Shihong Zhang, Huijun Xu, L. Chu, Wei-Ping Zhang, Qi Zhang, Zhong Chen, Ru-huan Mei, Meng-hui Zhao (2004)
Montelukast, a Cysteinyl Leukotriene Receptor-1 Antagonist, Dose- and Time-Dependently Protects against Focal Cerebral Ischemia in MicePharmacology, 73
R. Cojocariu, I. Balmuș, R. Lefter, D. Ababei, A. Ciobica, L. Hrițcu, Fatimazahra Kamal, B. Doroftei (2020)
Behavioral and Oxidative Stress Changes in Mice Subjected to Combinations of Multiple Stressors Relevant to Irritable Bowel SyndromeBrain Sciences, 10
M. Chowdhury, Uddin, Sriya Das, M. Hoque (2013)
Montelukast in Allergic Rhinitis: A ReviewMedicine Today, 24
Shenbao Wu, Xuxing Zhu, Zhonghai Jin, Xiuping Tong, Liqin Zhu, X. Hong, Xianfei Zhu, Pengfei Liu, W. Shen (2015)
The protective role of montelukast against intestinal ischemia-reperfusion injury in ratsScientific Reports, 5
K. Livak, Thomas Schmittgen
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method
西川 真司 (1994)
Effect of leukotriene C[4]D[4] antagonist on colonic damage induced by intracolonic administration of trinitrobenzene sulfonic acid in rats
E. Çikler, Y. Ersoy, Ş. Çetinel, F. Ercan (2009)
The leukotriene d4 receptor antagonist, montelukast, inhibits mast cell degranulation in the dermis induced by water avoidance stress.Acta histochemica, 111 2
Irritable bowel syndrome (IBS) is a functional gut disorder with multi-factorial pathophysiology that causes recurring pain or discomfort in the abdomen, as well as altered bowel habits. Montelukast, a well-known cysteinyl leukotriene receptor 1 (CysLT1R) antagonist, is widely used for the anti-inflammatory management of asthma. The present study aimed to evaluate the effects of pharmacological inhibition of CysLT1R on acetic acid-induced diarrhea-predominant IBS (D-IBS) in rats. Behavioral pain responses to noxious mechanical stimulation were decreased in the montelukast-treated rats as compared to the model animals following colorectal distension (CRD)-induced visceral hypersensitivity. Stool frequency decreased dose-dependently by montelukast in IBS rats exposed to restraint stress. A significantly shorter immobility time was also observed in IBS rats who received montelukast vs IBS group in the forced swimming test (depression-like behavior). Furthermore, there were significant decreases in the NF-κB protein expression, inflammatory cytokine (TNF-α, and IL-1ß) levels, and histopathological inflammatory injuries concomitant with increased anti-inflammatory cytokine, IL-10, in montelukast-treated rats compared with the IBS group. Cysteinyl leukotriene production and CysLT1R mRNA expression showed no remarkable differences among the experimental groups. The present results suggest the possible beneficial effects of montelukast in the management of D-IBS symptoms. The molecular mechanism underlying such effects, at least to some extent, might be through modulating CysLT1R-mediated NF-κB signaling. Yet, more studies are required to demonstrate the clinical potential of this drug for IBS therapy.
Inflammopharmacology – Springer Journals
Published: Feb 1, 2022
Keywords: Irritable bowel syndrome; Montelukast; Acetic acid; Visceral hypersensitivity; Inflammation; Rats
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.